Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Transposon to Present Results from Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 7th Annual ALS ONE Research Symposium
-
Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, MD and James Peterson to Board of Directors
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
EchoStar Corporation Announces Conference Call for Third Quarter 2024 Financial Results
-
Valona introduces cutting-edge foresight tools for global enterprises
-
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
-
Unwrap the Joy: Pinspark Fulfills Your Black Friday's Wishlist
-
D-Wave Achieves Significant Milestone with Calibration of 4,400+ Qubit Advantage2 Processor
-
Regis Corporation Reports Continued Profitability for the First Fiscal Quarter 2025
-
VSE Corporation Announces Third Quarter 2024 Results
-
Performance Food Group Company Reports First-Quarter Fiscal 2025 Results
-
Zevia Announces Third Quarter 2024 Results
-
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
-
Cellebrite Announces Third-Quarter 2024 Results
-
Laser Photonics Completes Acquisition of Control Micro Systems - Expands Into Pharmaceutical Laser Equipment Market
-
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s Annual Meeting
-
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
-
YHN Acquisition I Limited Announces the Separate Trading of its Ordinary Shares and Rights, Commencing November 8, 2024
-
WW International, Inc. Announces Third Quarter 2024 Results
-
Macerich Reports Third Quarter 2024 Results
-
Stella-Jones Announces Third Quarter Results and Updates 2023-2025 Financial Objectives
-
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
-
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
-
LENZ Therapeutics Reports Third Quarter 2024 Financial Results
-
The ODP Corporation Embarks on a New 10-Year, $1.5B Transformative Partnership with Nationally Recognized Strategic Reseller
-
ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results
-
Stella-Jones Announces Normal Course Issuer Bid
-
OMNI-LITE INDUSTRIES REPORTS THIRD QUARTER AND YEAR-TO-DATE FISCAL 2024 RESULTS
-
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
-
CECO Environmental Announces Upcoming Investor Conferences
-
Lantheus Reports Third Quarter 2024 Financial Results
-
Kaltura Announces Financial Results for Third Quarter 2024
-
Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
-
Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA
-
Use of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024
-
Employ Inc. Announces Promotion of Stephanie Manzelli to Chief Human Resources Officer
-
Brand Reputation Top Reason Home Security Shoppers Select System, J.D. Power Finds
-
Immunocore reports third quarter financial results and provides a business update
-
DATA Communications Management Corp. to Announce Third Quarter 2024 Results on November 12, 2024
-
Neumora Therapeutics to Participate in Upcoming Conferences in November
-
Valens Semiconductor Reports Third Quarter 2024 Results
-
RaceTrac Taps Vontier’s Invenco by GVR Remote Management Solution to Ensure High Uptime and Drive Operational and Cost Efficiencies
-
Eldorado Gold Announces Normal Course Issuer Bid
-
AEP Reports Third-Quarter 2024 Earnings, Introduces New Growth Rate and Capital Plan
-
SolasCure and U.S. Army Institute of Surgical Research Collaborate for Combat Wound Care
-
Johnson Controls Reports Q4 and FY24 Results; Initiates FY25 Guidance
-
QUANTA SERVICES TO PARTICIPATE IN INSTITUTIONAL INVESTOR CONFERENCES
-
Trimble Announces Third Quarter 2024 Results
-
YieldMax™ ETFs Announces Distributions on MRNY (73.00%), FBY (55.50%), DIPS (54.67%), YMAX (36.43%), YMAG (56.63%) and Others
-
MasTec Senior Management to Present at the Baird 2024 Global Industrial Conference

